Interaction between hypoxia, AKT and HIF-1 signaling in HNSCC and NSCLC: implications for future treatment strategies

Hanneke Stegeman1 Department of Radiation Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HBNijmegen, The Netherlands

Paul N Span1 Department of Radiation Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HBNijmegen, The NetherlandsCorrespondence[email protected]

Wenny JM Peeters1 Department of Radiation Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HBNijmegen, The Netherlands

Marieke MG Verheijen1 Department of Radiation Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HBNijmegen, The Netherlands

Reidar Grénman2 Department of Otorhinolaryngology-Head & Neck Surgery & Department of Medical Biochemistry, Turku University Hospital & University of Turku, Turku, Finland

Tineke WH Meijer1 Department of Radiation Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HBNijmegen, The Netherlands

Johannes HAM Kaanders1 Department of Radiation Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HBNijmegen, The Netherlands

Johan Bussink1 Department of Radiation Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HBNijmegen, The Netherlands

show all

Interaction between hypoxia, AKT and HIF-1 signaling in HNSCC and NSCLC: implications for future treatment strategies

Supplemental figure 1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Interaction between hypoxia, AKT and HIF-1 signaling in HNSCC and NSCLC: implications for future treatment strategies

Supplemental figure 1

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date